FLT3 and acute myeloid leukemia: Recently, new therapeutic scenarios have arisen in AML treatment, with the use of some small, oral molecule inhibitors, alone or in combination with classical chemotherapy or HMAs, such as tyrosine Fms-like tyrosine kinase 3 (FLT3) inhibitors.